Home > Boards > US Listed > Cannabis >

Charlotte's Web Holdings, Inc. (CWBHF)

Add CWBHF Price Alert      Hide Sticky   Hide Intro
Moderator: Monksdream, JohnCM, DD8, DarthYoda, ANIA77, kf3991
Search This Board: 
Last Post: 5/22/2019 2:47:03 AM - Followers: 132 - Board type: Free - Posts Today: 2

Charlotte's Web Holdings, Inc.
CA CSE: CWEB [CSE25 Index Member]

Charlotte's Web Holdings, Inc. (CWEB:CA) has gone public in Canada (CSE) via IPO on August 30th 2018
The latest in a growing list of U.S. businesses looking north of the border to raise capital.

The firm is the parent company of CW Hemp, the manufacturer of Charlotte’s Web CBD products, that was catapulted into the media spotlight in 2013 when it was featured in the CNN documentary “Weed.”

While the story of Charlotte’s Web garnered international exposure, little has been shared publicly about Stanley Brothers operations and financials – until now.
According to the firm’s preliminary prospectus Stanley Brothers, the company has been steadily posting an annual profit since 2016.

Other highlights from the filing include:

The firm has more than 170 employees, with hemp cultivation operations in northeastern Colorado.
It also has source contracts in place with farms in Kentucky and Oregon.

In 2017, the firm estimated its market share at roughly 14%, based on its $40 million in revenue in an estimated $287 million hemp CBD market.
The firm’s liquid products are priced from $39.99 to $274.99. Its capsules sell for $34.99 to $119.99.
For its fiscal 2018, the firm projects sales of $65 million to $80 million, with estimated annual adjusted EBITDA of $23 million to $30 million.

Charlotte's Web Holdings, Inc. Reports 2018 Q4 and Year-End Earnings

MARCH 28, 2019

Q4 revenue increases 21% QoQ to US$21.5 million

Full year revenue grew 74% to US$69.5M with 30% Adjusted EBITDA and US$0.14 EPS

BOULDER, CO, March 28, 2019 /CNW/ - Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company") (CSE:CWEB, OTCQX:CWBHF), the market share leader in hemp-derived CBD extract products, today reported financial results for the fourth quarter and year ended December 31, 2018. All amounts are expressed in United States dollars. Certain metrics, including those expressed on an adjusted basis, are non-IFRS measures.

Charlotte's Web by Stanley Brothers. Market share leader in whole-plant hemp extract products with naturally occurring CBD. (CNW Group/Charlotte''s Web Holdings, Inc.)

Highlights of Fourth Quarter 2018 Results versus Fourth Quarter 2017 Results

  • Organic consolidated revenue growth of 71% to $21.5 million (up 21% QoQ)
    Gross profit increased 63% to $16.3 million, or 76% of consolidated revenue
    Adjusted EBITDA decreased from 37% to 20% of consolidated revenue, due to extraordinary items
    Retail doors increased more than 80% to 3,680 at December 31, 2018
    57% of revenue from eCommerce
    2018 Farm Bill passed on December 20, 2018 removing hemp from the Federal CSA and designating it as an agricultural commodity governed by the USDA and FDA


Highlights of 2018 Full Year Results versus Full Year 2017 Results

  • Organic revenue growth of 74% to $69.5 million
    Gross profit increased 75% to $52.3 million, or 75% of consolidated revenue
    Adjusted EBITDA decreased from 36% to 30% of consolidated revenue


Highlights Subsequent to December 31, 2018

  • Executive leadership expansion with COO and CGO additions
    Record harvest of 675,000 pounds securing inventory to meet future demand
    Hemp Authority Certification received
    FDA commits to working with hemp industry on hemp product regulations
    First product orders shipped to three national retail grocery and drug chains in select locations


At the end of the fourth quarter the 2018 Farm Bill was successfully passed by U.S. Congress, providing the needed clarity and catalyst for expansion of the hemp industry. "We believe this important legislation will have a positive impact on consumer access to hemp-derived CBD products and for our valuable farming communities throughout the country," said Hess Moallem, President and Chief Executive Officer.  

"During the fourth quarter we concentrated our efforts on completing the 2018 harvest and building product inventory to support growing consumer demand," said Mr. Moallem.  "Our 2018 harvest resulted in 675,000 pounds of raw hemp compared to 63,000 pounds in 2017. The record harvest benefited from excellent growing conditions and the unique expertise we've accumulated over the past five years of cultivating the complex hemp plant. This inventory build ensures we are able to meet growing demand and supply the large national retail chains that are beginning to carry our products."

Product sales increased year-over-year with human nutrition products, topicals and animal nutrition products growing by 76%, 1085% and 189%, respectively. (The canine line is growing from a smaller base as it was launched in February of 2018.) "In general, broader consumer awareness of the benefits of cannabinoids, namely cannabidiol (CBD) from hemp extract, is driving increased uptake in all product categories in our retail channels and e-commerce platform," added Mr. Moallem.

The Company has been actively adding additional retail distribution customers and locations. Initially available in natural health stores throughout the United States, increased education and understanding of hemp extract has been driving demand for Charlotte's Web products through ever larger retail chains. The Company recently surpassed 4,000 locations after national retail chains began carrying Charlotte's Web products.  Today, Charlotte's Web can be found on the shelves at a growing number of national brand grocery and drug chains in select stores and states.

Charlotte's Web is the market leader in the rapidly expanding hemp-derived CBD wellness markets, dedicated to producing the highest quality products and efficacy. Several new products and formats are planned for 2019 in animal nutrition, wellness topicals and human consumables.

Fourth Quarter and Year-to-Date 2018 Results

Revenue for the quarter ended December 31, 2018 (Q4-2018) totaled $21.5 million, compared to $12.6 million for the same period in 2017, representing a 71% increase. On a year-over-year basis for Q4-2018, e-commerce revenue grew by 58% and wholesale, distributor and retail revenue grew by 76%. During Q4 2018 and 2017, e-commerce sales accounted for 57% and 59% of total sales, respectively. Revenue from human nutrition products, topicals and animal nutrition products grew by 73%, 373% and 126%, respectively (the Company's canine products were introduced in February of 2017).

Revenue for the year 2018 totaled $69.5 million, compared to $40.0 million for 2017, representing a 74% increase. On a year-over-year basis for 2018, e-commerce revenue grew by 51% and wholesale, distributor and retail revenue grew by 126%. For 2018, revenue from human nutrition, topical and canine products grew by 76%, 1085% and 189%, respectively. The Company's topical and canine products each accounted for approximately 4% of total revenue during 2018.

Gross profit totaled $16.3 million for Q4- 2018, compared to $10.0 million for the same period in 2017, a year-over-year increase of 63%. As a percent of total revenue, gross profit in Q4-2018 was 76%, compared to 80% for the same period in 2017.

Gross profit totaled $52.3 million for 2018, compared to $29.9 million for the same period in 2017, a year-over-year increase of 75%. As a percent of total revenue, gross profit for 2018 and 2017 was 75%. 

The Company used $2.4 million of cash in operations during Q4-2018 compared to $2.7 million of cash provided from operations during Q4-2017. The reduction in cash flows from operations primarily reflects the investment in inventory associated with the 2018 hemp crop and other raw materials used in the production process in anticipation of materially increasing revenue opportunities. The Company's cash at December 31, 2018 was $73.4 million compared to $7.1 million on December 31, 2017. Working capital at December 31, 2018 was $93.8 million.



Charlotte's Web has 24,095,294 Common Shares outstanding and 172,896.15 Proportionate Voting Shares convertible at 400:1, for an effective equivalent of 93,253,754 Common Shares outstanding. 

Corporate Website: http://www.cwhemp.com/


Charlotte’s Web Holdings Inc.
Investor Relations
2425 55th Street, Suite 200
Boulder, Colorado, 80301

Email:  InvestorRelations@CWhemp.com

Phone: (416) 594-3849




Toronto, Ontario – October 31, 2018 – Corriente Master Fund II, LP (“Corriente”) announced that effective October 29, 2018 it has increased its ownership in the capital of Charlotte’s Web Holdings, Inc. (the “Issuer”) by another 2% through acquisitions on the Canadian Securities Exchange (the “CSE”). Together with the 2,149,700 common shares of the Issuer previously owned by Corriente, which represented approximately 12.46% of the then issued and outstanding common shares of the Issuer and approximately 2.32% of the then total voting rights of the Issuer, Corriente now owns and controls a total of 2,592,500 common shares of the Issuer, or approximately 15.03% of the issued and outstanding common shares of the Issuer and approximately 2.79% of the total voting rights of the Issuer. Corriente Advisors, LLC is the investment manager of Corriente. Corriente acquired the common shares for investment purposes, and may acquire further common shares or dispose of its holdings of the common shares, as investment conditions warrant. The Issuer is listed on the CSE under the symbol “CWEB”.



Charlotte's Web CEO Hess Moallem appeared on CNBC Squawk on the Street this morning. The interview aired just before 11am ET and touched on a handful of topics including the legalization of marijuana in Canada and its potential impact on the CBD market, broader cannabis regulations in the U.S., sales of Charlotte’s Web products in the U.S. as a core market with plans to expand internationally, and the Bi-partisan support for the Farm Bill.

Hess concluded by reminding the audience that Charlotte’s Web, unlike many cannabis companies, has established revenue, significant profitability and is focused on the momentum of its market share expansion.

The interview can be viewed here: https://www.cnbc.com/video/2018/10/17/canada-marijuana-cannabis.html


CBD Leader Charlotte’s Web Holdings, Inc. Surpasses 3000 Locations as Mainstream Market Grows

BOULDER, COLORADO, October 16, 2018 — (CSE: CWEB; OTCQX: CWBHF) Charlotte’s Web Holdings, Inc. (“Charlotte’s Web” or the “Company”), the market share leader in hemp-based CBD wellness products, has surpassed 3000 retail locations across the United States. At the end of 2017, Charlotte’s Web products were sold in approximately 2,000 locations. The Company disclosed today that it surpassed its 2018 year-end goal of 3,000 locations during the 3 rd quarter. “Firstly, I would like to commend our incredible and committed staff who worked tirelessly to achieve this milestone,” stated Charlotte’s Web CEO Hess Moallem. “I would also like to thank our dedicated retail partners for their continued support of our mission and for valuing the trust that is closely associated with our brand name.” With CBD gaining mainstream market momentum, Charlotte’s Web, the industry pioneer and category leader in hemp-based CBD, has expanded its suite of product offerings across a wider variety of retailers, from small specialty health food stores to now including regional pharmacy and grocery chains. The Company recently added more than 40 Bartell drug stores in the North West. Mr. Moallem added, “While we are thrilled to beat our retail expectations for the year, we know this is just the beginning of our continued expansion both domestically and worldwide. We are deeply committed to the millions of people who benefit from Charlotte’s Web and we will continue breaking new ground to ensure our products are made available in as many retail locations as possible.” In September at Natural Products EXPO East 2018, Charlotte’s Web took home The NEXTY Consumer Choice Award. The NEXTY Award recognizes innovative natural products that inspire and uphold industry integrity. Charlotte’s Web was selected from a group of 57 finalists. The Company recently completed a brand and consumer packaging refresh.

Charlotte’s Web is a market leader in cannabis CBD, says M Partners

"M Partners analyst Damian Karp is bullish on US cannabis company Charlotte’s Web Holdings (Charlotte’s Web Holdings Stock Quote, Chart CSE:CWEB), saying the makers of CBD wellness products should be able to maintain its market-leading position as it expands both domestically and internationally."


This Marijuana Stock Has a Clear Path to Uplist to the Nasdaq or NYSE

"The Farm Bill's passage should allow this $2 Billion pot stock to move to a more reputable exchange."


Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CWBHF News: Celebrity Attention Fuels Rising Press Profile of CBD 05/21/2019 08:45:00 AM
CWBHF News: Hemp Companies Move to Tackle CBD Shortfall 05/14/2019 08:45:00 AM
CWBHF News: Increasing Growth, Acceptance Move CBD Market Toward Mainstream 04/09/2019 08:45:00 AM
CWBHF News: CBD Beverages – Possible Next Big Disruptor in the Drinks Industry 03/20/2019 08:45:00 AM
CWBHF News: Savvy Companies Seizing Opportunities in Growing Cannabis Market 03/14/2019 08:45:00 AM
News News Alert: Celebrity Attention Fuels Rising Press Profile of CBD 05/21/2019 08:45:00 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
#933  Sticky Note CWBHF had diluted Shares: 106.5 million on 11/20/18. DD8 11/29/18 04:12:38 PM
#787  Sticky Note John Boehner (Former Speaker of the United States Rockhall 10/24/18 07:39:15 AM
#435  Sticky Note CHARLOTTE'S WEB HOLDINGS COVERAGE by Canaccord Genuity ANIA77 10/02/18 09:12:23 PM
#7891   I am sensing some COGNITIVE DISSONANCE: Gladys Thong 05/22/19 02:47:02 AM
#7890   Well that was a bit of a nasty nowwhat2 05/22/19 01:22:55 AM
#7889   Its original investors and some insider enrichment time. All in on Weed 05/21/19 09:28:58 PM
#7888   Cali CBD news https://greencamp.com/california-on-a-fast-track-to-cbd-sales-lega super_trades 05/21/19 05:46:35 PM
#7887   ?Big pharma will make aggressive moves into cannabis super_trades 05/21/19 05:16:11 PM
#7886   Check pps when locked up period was expiring ANIA77 05/21/19 05:01:21 PM
#7885   Okay Charlotte.....Come sit down. nowwhat2 05/21/19 04:29:26 PM
#7884   How else do explain why we dropped to mc73 05/21/19 04:17:20 PM
#7883   Def see an easy double this summer. make it happen 05/21/19 04:13:15 PM
#7882   When mgmt finally speaks up with big strategic super_trades 05/21/19 04:04:33 PM
#7881   It will be the CGC of the space super_trades 05/21/19 04:03:31 PM
#7880   They will be there much sooner if you super_trades 05/21/19 04:02:45 PM
#7879   I'm the biggest donor of joy. nowwhat2 05/21/19 04:01:01 PM
#7878   there aren't any clinical trials with CW that JohnCM 05/21/19 03:48:25 PM
#7877   The Price Drop - GET REAL ! Gladys Thong 05/21/19 03:41:52 PM
#7876   I think this will be the pure play make it happen 05/21/19 03:41:41 PM
#7875   In 5 years they will be at over mc73 05/21/19 03:39:16 PM
#7874   CW planting crazy yield harvest this year they super_trades 05/21/19 03:20:13 PM
#7873   It has been a tough two months for JohnCM 05/21/19 02:25:50 PM
#7872   ELLXF (I have no position) trades well , super_trades 05/21/19 01:44:08 PM
#7871   Bingo. Let other companies pay for expensive trials. mc73 05/21/19 01:39:28 PM
#7870   Yeah, Bill Alpert always seems to be high WhiteSpace 05/21/19 01:20:36 PM
#7869   No doubt they have been doing research. There ANIA77 05/21/19 01:11:00 PM
#7868   e/r 28th with cc morning of 29th deadjim 05/21/19 01:08:07 PM
#7867   key push is through 16-16.20 area. nowwhat2 05/21/19 12:54:03 PM
#7866   CW given little respect in this Barron's article super_trades 05/21/19 12:53:51 PM
#7865   there aren't any clinical trials with CW that deadjim 05/21/19 12:40:07 PM
#7864   Wouldn't a company have to disclose whether or nowwhat2 05/21/19 12:36:17 PM
#7863   We should hear more at the FDA meeting kf3991 05/21/19 12:17:26 PM
#7862   Agree with that sir super_trades 05/21/19 12:16:12 PM
#7861   You THINK they're doing trials ?..... nowwhat2 05/21/19 12:15:31 PM
#7860   Perhaps earnings release will break us up and mc73 05/21/19 12:07:34 PM
#7859   Wish we had the aggressiveness of CGC leadership super_trades 05/21/19 12:01:04 PM
#7858   CW is doing research and I think trials super_trades 05/21/19 12:00:25 PM
#7857   FDA and the U.S. government are way behind JohnCM 05/21/19 11:51:13 AM
#7856   i disagree respectfully that it told market what super_trades 05/21/19 11:47:51 AM
#7855   The sale of shares at $15 told the mc73 05/21/19 11:39:00 AM
#7854   Yeah I was wondering if he had a ANIA77 05/21/19 11:01:09 AM
#7853   Clinical results? deadjim 05/21/19 10:53:51 AM
#7852   Steady as she goes ... JohnCM 05/21/19 10:46:01 AM
#7851   VALX back stopping pops jgusciora 05/21/19 10:44:40 AM
#7850   And like....ya' can't post the chart of that ? nowwhat2 05/21/19 10:22:06 AM
#7849   Let's close above MA100 and get that MACD ANIA77 05/21/19 09:52:56 AM
#7848   I agree, my conviction for 5-10B cap is super_trades 05/21/19 09:39:29 AM
#7847   Within the United States, CBD producer Charlotte’s Web JohnCM 05/21/19 09:32:52 AM
#7846   You are in a good place. Super solid JohnCM 05/21/19 09:24:35 AM
#7845   Seems like we do. I’m patient, but this CannaBeast 05/21/19 09:16:26 AM
#7844   Also keep in mind, it is not all JohnCM 05/21/19 09:10:15 AM
#7843   Old but interesting little study... very biased as kf3991 05/21/19 08:57:52 AM
#7842   Hoping CW can start making strategic moves. super_trades 05/21/19 08:54:41 AM